The Health Decisions event team is looking forward to a productive DIA in Washington, DC June 14-18. Vice President, Clinical Affairs Patrick Phillips, D Phil, will lead a forum on project management of adaptive trials and Health Decisions experts will be available through booth #821 to discuss clinical development trends and challenges with sponsors. In addition, Health Decisions will hold a drawing for an Apple Watch – an attractive reminder that technology plays a central role in enabling project teams to meet clinical development timelines. (The Apple Watch is pictured with a custom-made Health Decisions band.)
The forum chaired by Dr. Phillips is entitled “Project Management of Adaptive Trials: Infrastructure and Methodology.” It is session 103 in DIA’s “Project/Portfolio Management and Strategic Planning” track and will take place June 15, 8:30AM – 10:00AM, in Room 101, Level One South, of the Walter E. Washington Convention Center. The forum will be invaluable to companies exploring adaptive trial designs but uncertain about operational complexity.
We encourage you to stop by booth #821 to discuss clinical development trends or your specific development challenges. You can visit the booth at your convenience but to ensure the most productive discussions of your development issues, it is advisable to schedule a meeting with Health Decisions experts in advance. Calendars are filling up quickly. If you will not be attending DIA, we would be happy to schedule a meeting after the event at your convenience.
Wearable Technology and Clinical Trials
In addition to holding a drawing for an Apple Watch, Health Decisions has provided Apple Watches to the team manning our booth. We are always open to new technology and our early experiments with Apple Watches raise intriguing possibilities about the potential role of health tracking apps in clinical trials. The evolution of Apple’s ResearchKit should offer a wider range of possibilities when coupled with a small wearable device like the Apple Watch.
Potential in Endocrine and Metabolism
Endocrinologists who are active in clinical research, like Health Decisions CEO Stephen DeCherney, MD, MPH, see intriguing possibilities in the combination of wearable devices, wireless connections with glucometers and insulin pumps and health tracking apps for diabetics. Mass General’s GlucoSuccess, created with Apple’s ResearchKit, is a harbinger of more powerful apps to come. Steve notes that in both patient care and clinical research, patient self-reporting and HbA1c results are often at odds. He hopes that wearable devices and health tracking apps will enable an earlier and better understanding of actual patient behavior, potentially valuable in interpretation of patient response to both investigational and approved drugs.